Edition:
United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

29.30HKD
23 Aug 2019
Change (% chg)

HK$0.45 (+1.56%)
Prev Close
HK$28.85
Open
HK$28.85
Day's High
HK$29.30
Day's Low
HK$28.65
Volume
7,262,501
Avg. Vol
6,330,846
52-wk High
HK$41.05
52-wk Low
HK$25.70

Tan, Wee Seng 

Mr. Tan Wee Seng is an Independent Non-Executive Director of the company. He has served as a non-executive Director since 21 September 2014 and has more than 40 years of working experience. Mr. Tan is a Chartered Global Management Accountant, Fellow member of the Chartered Institute of Management Accountants in United Kingdom, and the Hong Kong Institute of Directors. Mr. Tan has been with Reuters Group from April 1984 to June 2002. Mr. Tan served as executive director, chief finance officer and company secretary of Li Ning Company Limited (a company listed on the Hong Kong Stock Exchange), from January 2003 to November 2008. Mr Tan was an independent director and chairman of the audit committee of 7 Days Holdings Limited (whose shares were listed on the New York Stock Exchange between November 2009 to July 2013) until it was privatized. He was the Chairman of the Special Committee for Privatization of 7 Days Holdings Limited from October 2012 to July 2013. Mr. Tan currently also serves as independent non-executive director of each of Biostime International Holdings Limited (a company listed on the Hong Kong Stock Exchange), Sa Sa International Holdings Limited (a company listed on the Hong Kong Stock Exchange), CIFI Holdings (Group) Company Limited (a company listed on the Hong Kong Stock Exchange), Xtep International Holdings Limited (a company listed on the Hong Kong Stock Exchange), he is also an independent director of ReneSola Ltd. (a company listed on the New York Stock Exchange) and a director and chairman of finance and operation committee of Beijing City International School.

Basic Compensation

Total Annual Compensation, CNY 300,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 300,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li

6,572,000

Yong Liu

7,489,000

Qiyu Chen

--

Xiuchang Jiang

--

Maisong Cai

--

Jun Lu

--
As Of  31 Dec 2017